Thomas C. VanCott
About
Thomas C. VanCott is a scholar working on Virology, Infectious Diseases and Immunology.
According to data from OpenAlex, Thomas C. VanCott has authored 74 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Virology, 36 papers in Infectious Diseases and 22 papers in Immunology. Recurrent topics in Thomas C. VanCott's work include HIV Research and Treatment (69 papers), HIV/AIDS Research and Interventions (20 papers) and HIV/AIDS drug development and treatment (18 papers). Thomas C. VanCott is often cited by papers focused on HIV Research and Treatment (69 papers), HIV/AIDS Research and Interventions (20 papers) and HIV/AIDS drug development and treatment (18 papers). Thomas C. VanCott collaborates with scholars based in United States, Thailand and France. Thomas C. VanCott's co-authors include John R. Mascola, Deborah L. Birx, Mark G. Lewis, Hermann Katinger, Sarah S. Frankel, Gabriela Stiegler, D L Birx, Merlin L. Robb, Thomas C. Quinn and Nelson K. Sewankambo and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Medicine.
In The Last Decade
Thomas C. VanCott
73 papers receiving 5.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thomas C. VanCott United States | 36 | 4.1k | 2.4k | 2.2k | 1.6k | 1.0k | 74 | 5.6k | ||
| Carolyn Williamson South Africa | 40 | 4.2k 1.0× | 2.9k 1.2× | 2.2k 1.0× | 1.4k 0.9× | 1.3k 1.3× | 158 | 7.1k | ||
| Gunnel Biberfeld Sweden | 50 | 4.0k 1.0× | 3.4k 1.5× | 2.4k 1.1× | 2.9k 1.9× | 854 0.8× | 275 | 8.2k | ||
| Jonathan Weber United Kingdom | 58 | 5.4k 1.3× | 4.2k 1.8× | 4.5k 2.0× | 2.1k 1.4× | 1.0k 1.0× | 216 | 10.3k | ||
| Haynes W. Sheppard United States | 41 | 4.0k 1.0× | 3.8k 1.6× | 1.8k 0.8× | 1.8k 1.2× | 862 0.8× | 89 | 7.0k | ||
| Merlin L. Robb United States | 45 | 4.8k 1.2× | 4.0k 1.7× | 2.4k 1.1× | 1.8k 1.2× | 1.1k 1.1× | 249 | 7.8k | ||
| Donald N. Forthal United States | 38 | 3.5k 0.8× | 2.3k 1.0× | 2.6k 1.2× | 1.9k 1.2× | 1.3k 1.2× | 100 | 6.3k | ||
| J Michael Kilby United States | 26 | 5.2k 1.3× | 3.7k 1.6× | 2.0k 0.9× | 1.4k 0.9× | 1.2k 1.2× | 53 | 6.5k | ||
| Agegnehu Gettie United States | 43 | 5.2k 1.3× | 2.7k 1.1× | 3.2k 1.4× | 2.0k 1.3× | 685 0.7× | 113 | 6.8k | ||
| Thumbi Ndung’u South Africa | 48 | 4.0k 1.0× | 3.4k 1.4× | 2.7k 1.2× | 2.1k 1.4× | 1.3k 1.2× | 273 | 7.6k | ||
| S. Chamaret France | 24 | 6.6k 1.6× | 4.1k 1.8× | 3.9k 1.8× | 2.3k 1.5× | 1.3k 1.3× | 37 | 9.4k |
Countries citing papers authored by Thomas C. VanCott
Since
Specialization
Citations
This map shows the geographic impact of Thomas C. VanCott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. VanCott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. VanCott more than expected).
Fields of papers citing papers by Thomas C. VanCott
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Thomas C. VanCott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. VanCott. The network helps show where Thomas C. VanCott may publish in the future.
Co-authorship network of co-authors of Thomas C. VanCott
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. VanCott. A scholar is included among the top collaborators of Thomas C. VanCott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. VanCott. Thomas C. VanCott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Brook, Byron, Valérie Duval, Soumik Barman, et al.. (2024). Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70. Science Translational Medicine. 16(757). eadm8451–eadm8451.
2.
Brown, Bruce K., Josephine H. Cox, Thomas C. VanCott, et al.. (2010). Phase I Study of Safety and Immunogenicity of an Escherichia coli-Derived Recombinant Protective Antigen (rPA) Vaccine to Prevent Anthrax in Adults. PLoS ONE. 5(11). e13849–e13849.
3.
Beddows, Simon, Marc W. Kirschner, Michael Franti, et al.. (2006). Construction and Characterization of Soluble, Cleaved, and Stabilized Trimeric Env Proteins Based on HIV Type 1 Env Subtype A. AIDS Research and Human Retroviruses. 22(6). 569–579.
4.
Ignatius, Ralf, Michael A. Eller, Kevin A. Wilkinson, et al.. (2004). Macaque Dendritic Cells Infected with SIV-Recombinant Canarypox ex Vivo Induce SIV-Specific Immune Responses in Vivo. AIDS Research and Human Retroviruses. 20(8). 871–884.
5.
Ginkel, Frederik W. van, John L. VanCott, Robert W. Kaminski, & Thomas C. VanCott. (2003). Measurement of HIV-1 Specific and Total Antibody Secreting Cells by ELISPOT. Humana Press eBooks. 17. 283–292.
6.
Wright, Peter F., Pamela A. Kozlowski, Paul A. Goepfert, et al.. (2002). Detection of Mucosal Antibodies in HIV Type 1-Infected Individuals. AIDS Research and Human Retroviruses. 18(17). 1291–1300.
7.
Farquhar, Carey, Thomas C. VanCott, Dorothy Mbori‐Ngacha, et al.. (2002). Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast Milk. The Journal of Infectious Diseases. 186(8). 1173–1176.
8.
Polonis, Victoria R., Mark de Souza, Penprapa Chanbancherd, et al.. (2001). HIV Type 1 Subtype E-Infected Patients with Broadened, Dual (B/E) V3 Loop Serology Have Increased Cross-Neutralizing Antibodies. AIDS Research and Human Retroviruses. 17(1). 69–79.
9.
Kim, Jerome H., John R. Mascola, Silvia Ratto‐Kim, et al.. (2001). Selective Increases in HIV-Specific Neutralizing Antibody and Partial Reconstitution of Cellular Immune Responses during Prolonged, Successful Drug Therapy of HIV Infection. AIDS Research and Human Retroviruses. 17(11). 1021–1034.
10.
Mascola, John R., Gabriela Stiegler, Thomas C. VanCott, et al.. (2000). Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nature Medicine. 6(2). 207–210.
11.
Górny, Miroslaw K., Thomas C. VanCott, Constance Williams, Kathy Revesz, & Susan Zolla‐Pazner. (2000). Effects of Oligomerization on the Epitopes of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins. Virology. 267(2). 220–228.
12.
Lambert, John S., James McNamara, Samuel L. Katz, et al.. (1998). Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-Infected Infants and Children. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(5). 451–461.
13.
Górny, Miroslaw K., John R. Mascola, Zimra R. Israel, et al.. (1998). A Human Monoclonal Antibody Specific for the V3 Loop of HIV Type 1 Clade E Cross-Reacts with Other HIV Type 1 Clades. AIDS Research and Human Retroviruses. 14(3). 213–221.
14.
VanCott, Thomas C., Robert W. Kaminski, John R. Mascola, et al.. (1998). HIV-1 Neutralizing Antibodies in the Genital and Respiratory Tracts of Mice Intranasally Immunized with Oligomeric gp160. The Journal of Immunology. 160(4). 2000–2012.
15.
Loomis‐Price, Lawrence D., Josephine H. Cox, John R. Mascola, et al.. (1998). Correlation between Humoral Responses to Human Immunodeficiency Virus Type 1 Envelope and Disease Progression in Early‐Stage Infection. The Journal of Infectious Diseases. 178(5). 1306–1316.
16.
Mason, Carl J., Lauri E. Markowitz, Penprapa Chanbancherd, et al.. (1998). Nationwide Surveillance of HIV-1 Prevalence and Subtype in Young Thai Men. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(2). 165–173.
17.
Artenstein, Andrew W., Thomas C. VanCott, Karl Sitz, et al.. (1997). Mucosal Immune Responses in Four Distinct Compartments of Women Infected with Human Immunodeficiency Virus Type 1: A Comparison by Site and Correlation with Clinical Information. The Journal of Infectious Diseases. 175(2). 265–271.
18.
Gaywee, Jariyanart, Andrew W. Artenstein, Thomas C. VanCott, et al.. (1996). Correlation of Genetic and Serologic Approaches to HIV-1 Subtyping in Thailand. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 13(4). 392–396.
19.
VanCott, Thomas C., et al.. (1995). Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen. Journal of Immunological Methods. 183(1). 103–117.
20.
VanCott, Thomas C., Lawrence D. Loomis, Robert R. Redfield, & Deborah L. Birx. (1992). Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1. Journal of Immunological Methods. 146(2). 163–176.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Carolyn Williamson Breakdown of academic impact, for papers by Gunnel Biberfeld Breakdown of academic impact, for papers by Jonathan Weber Breakdown of academic impact, for papers by Haynes W. Sheppard Breakdown of academic impact, for papers by Merlin L. Robb Breakdown of academic impact, for papers by Donald N. Forthal Breakdown of academic impact, for papers by J Michael Kilby Breakdown of academic impact, for papers by Agegnehu Gettie Breakdown of academic impact, for papers by Thumbi Ndung’u Breakdown of academic impact, for papers by S. Chamaret